Carolina de Aguiar Ferreira, PhD
Assistant Professor
Radiology, Pharmacology & Toxicology
Radiology, Pharmacology & Toxicology
4113 iQ Building
Research
Colleges
Works
- EGFR- and Integrin αVβ3-Targeting Peptides as Potential Radiometal-Labeled Radiopharmaceuticals for Cancer Theranostics. International Journal of Molecular Sciences (2024-08-05)
- EGFR- and Integrin αVβ3-Targeting Peptides as Potential Radiometal-Labeled Radiopharmaceuticals for Cancer Theranostics. International Journal of Molecular Sciences (2024)
- Immune Checkpoint Inhibitor-Mediated Cancer Theranostics with Radiolabeled Anti-Granzyme B Peptide. Pharmaceutics (2022-07-13)
- CD38-Targeted Theranostics of Lymphoma with 89Zr/177Lu-Labeled Daratumumab. Advanced Science (2021)
- ImmunoPET of CD146 in Orthotopic and Metastatic Breast Cancer Models. Bioconjugate Chemistry (2021)
- Non-invasive detection of immunotherapy-induced adverse events. Clinical Cancer Research (2021)
- Ultrasmall Porous Silica Nanoparticles with Enhanced Pharmacokinetics for Cancer Theranostics. Nano Letters (2021)
- Voices in Molecular Pharmaceutics: Meet Dr. Carolina Ferreira, Who Is Developing the Next Generation of Radioactive Theranostics. Molecular Pharmaceutics (2021)
- pH-responsive and folate-coated liposomes encapsulating irinotecan as an alternative to improve efficacy of colorectal cancer treatment. Biomedicine and Pharmacotherapy (2021)
- 86/90Y-Labeled Monoclonal Antibody Targeting Tissue Factor for Pancreatic Cancer Theranostics. Molecular Pharmaceutics (2020)
- Ag2WO4 nanoparticles radiolabeled with technetium-99m: a potential new tool for tumor identification and uptake. Journal of Radioanalytical and Nuclear Chemistry (2020)
- Granzyme B PET imaging for assessment of disease activity in inflammatory bowel disease. Journal of Nuclear Medicine (2020)
- HER3 PET Imaging Predicts Response to Pan-Receptor Tyrosine Kinase Inhibtion Therapy in Gastric Cancer. Journal of Nuclear Medicine (2020)
- HPMA-based star polymer biomaterials with tuneable structure and biodegradability tailored for advanced drug delivery to solid tumours. Biomaterials (2020)
- Internally Responsive Nanomaterials for Activatable Multimodal Imaging of Cancer. Advanced Healthcare Materials (2020)
- Non-Invasive Detection of Immunotherapy-induced Adverse Events. Journal of Nuclear Medicine (2020)
- Selenium-Doped Carbon Quantum Dots Act as Broad-Spectrum Antioxidants for Acute Kidney Injury Management. Advanced Science (2020)
- Y-86/90-Labeled Monoclonal Antibody Targeting Tissue Factor for Pancreatic Cancer Theranostics. Molecular Pharmaceutics (2020)
- A "Missile-Detonation" Strategy to Precisely Supply and Efficiently Amplify Cerenkov Radiation Energy for Cancer Theranostics. Advanced Materials (2019)
- A “Missile-Detonation” Strategy to Precisely Supply and Efficiently Amplify Cerenkov Radiation Energy for Cancer Theranostics. Advanced Materials (2019)
- Antibody and fragment-based PET imaging of CTLA-4+T-cells in humanized mouse models. American Journal of Cancer Research (2019)
- Cerenkov Radiation-Induced Photodynamic Therapy Amplified by Magnetic Nanotheranostics. Journal of Nuclear Medicine (2019)
- Ceria Nanoparticles Meet Hepatic Ischemia-Reperfusion Injury: The Perfect Imperfection. Advanced Materials (2019)
- Cu-68-labeled F(ab')(2) fragments of daratumumab for early visualization of CD38-positive lymphoma. Journal of Nuclear Medicine (2019)
- Dual-labeled pertuzumab for multimodality image-guided ovarian tumor resection. American Journal of Cancer Research (2019)
- Imaging CTLA-4+T-cells in humanized mouse models. Journal of Nuclear Medicine (2019)
- Imaging PD-L1 expression in tumors follo ng radiotherapy treatment. Journal of Nuclear Medicine (2019)
- Manganese ions chelated melanin ultra-small nanostructure for PET/MR bimodal imaging-guided acute kidney injury therapy. Journal of Nuclear Medicine (2019)
- Noninvasive visualization of the differential expression of CD146 in breast cancer. Journal of Nuclear Medicine (2019)
- PET imaging of pre-synaptic protein SV2A in Rett syndrome mouse model. Journal of Nuclear Medicine (2019)
- Polyoxometalate Clusters as Multi-antioxidants to Ameliorate Acute Kidney Injury in Mice. Journal of Nuclear Medicine (2019)
- Radionuclide-Activated Nanomaterials and Their Biomedical Applications. Angewandte Chemie International Edition (2019)
- Renal-Accumulating Selenium-Doped Carbon Quantum Dots Treat Acute Kidney Injury in Mice. Journal of Nuclear Medicine (2019)
- Safe and dosimetry evaluation of radimmmunotherapy using Lu-177-labeled antibodies in lymphoma. Journal of Nuclear Medicine (2019)
- Size-Optimized Ultrasmall Porous Silica Nanoparticles Depict Vasculature-Based Differential Targeting in Triple Negative Breast Cancer. Small (2019)
- Surfactant-Stripped Pheophytin Micelles for Multimodal Tumor Imaging and Photodynamic Therapy. ACS Applied Bio Materials (2019)
- Y-86/90-based theranostics targeting tissue factor in a pancreatic tumor model. Journal of Nuclear Medicine (2019)
- Zirconium-89 radiolabeled hollow ferulic acid nanostructure for PET imaging guided acute kidney injury therapy. Journal of Nuclear Medicine (2019)
- Activatable Hybrid Nanotheranostics for Tetramodal Imaging and Synergistic Photothermal/Photodynamic Therapy. Advanced Materials (2018)
- Antiangiogenic evaluation of ZnWO4 nanoparticles synthesised through microwave-assisted hydrothermal method. Journal of Drug Targeting (2018)
- Antiangiogenic evaluation of ZnWO4 nanoparticles synthesised through microwave-assisted hydrothermal method. Journal of Drug Targeting (2018)
- Antibody and Fragment-Based PET Imaging of CTLA-4+T-Cells in Humanized Mouse Models. Medical Physics (2018)
- DNA tetrahedron nanoparticles enable kidney function assessment in mice with unilateral ureteral obstruction. Journal of Nuclear Medicine (2018)
- Effective weight control via an implanted self-powered vagus nerve stimulation device. Nature Communications (2018)
- Efficient Uptake of Lu-177-Porphyrin-PEG Nanocomplexes by Tumor Mitochondria for Multimodal-Imaging-Guided Combination Therapy. Angewandte Chemie International Edition (2018)
- Efficient Uptake of 177Lu-Porphyrin-PEG Nanocomplexes by Tumor Mitochondria for Multimodal-Imaging-Guided Combination Therapy. Angewandte Chemie - International Edition (2018)
- Exogenous Radionanomedicine: Inorganic Nanomaterials. Radionanomedicine: Combined Nuclear and Nanomedicine (2018)
- ImmunoPET of CD146 in a Murine Hindlimb Ischemia Model. Molecular Pharmaceutics (2018)
- Implanted Battery-Free Direct-Current Micro-Power Supply from in Vivo Breath Energy Harvesting. ACS Applied Materials & Interfaces (2018)
- In vivo PET imaging of CD20 using Cu-64-labeled F(ab)2 fragment of obinumumab in lymphoma models. Journal of Nuclear Medicine (2018)
- Magnetic Targeting of Nanotheranostics Enhances Cerenkov Radiation-Induced Photodynamic Therapy. Journal of the American Chemical Society (2018)
- Markedly Enhanced Magnetic Resonance Imaging-Guided Photothermal Therapy with Oxygen Vacancy Regulation. Journal of Nuclear Medicine (2018)
- Radiolabeled Nanostructured Porphyrin-PEG Mesh for Efficient Tumor Targeting and Multimodal Image-Guided Combination Therapy. Journal of Nuclear Medicine (2018)
- Scavenging of reactive oxygen and nitrogen species with nanomaterials. Nano Research (2018)
- Targeting angiogenesis for radioimmunotherapy with a Lu-177-labeled antibody. European Journal of Nuclear Medicine and Molecular Imaging (2018)
- Targeting angiogenesis for radioimmunotherapy with a 177Lu-labeled antibody. European Journal of Nuclear Medicine and Molecular Imaging (2018)
- Theranostics of Murine Breast Cancer with a 86/90Y-Labeled Antibody. Medical Physics (2018)
- Theranostics of lymphoma with Zr-89- and Lu-177-labeled daratumumab. Journal of Nuclear Medicine (2018)
- Vasculature-based differential tumor uptake of radiolabeled Ultrasmall Mesoporous Silica Nanoparticles in breast cancers models. Journal of Nuclear Medicine (2018)
- Vincristine-loaded hydroxyapatite nanoparticles as a potential delivery system for bone cancer therapy. Journal of Drug Targeting (2018)
- Y-86/90-Based Theranostics Targeting Angiogenesis in a Murine Breast Cancer Model. Molecular Pharmaceutics (2018)
- 86/90 Y-Based Theranostics Targeting Angiogenesis in a Murine Breast Cancer Model. Molecular Pharmaceutics (2018)
- Y-86/90-Labeled Ultrasmall Mesoporous Silica Nanoparticles for Cancer Theranostics. Journal of Nuclear Medicine (2018)
- Y-86/90-based theranostics of breast cancer in a preclinical model. Journal of Nuclear Medicine (2018)
- Radiolabeled bombesin derivatives for preclinical oncological imaging. Biomedicine & Pharmacotherapy (2017)
- The role of radionuclide probes for monitoring anti-tumor drugs efficacy: A brief review. Biomedicine & Pharmacotherapy (2017)
- Development of imaging probes for bone cancer in animal models. A systematic review. Biomedicine & Pharmacotherapy (2016)
- Engineering of radiolabeled iron oxide nanoparticles for dual-modality imaging. Wiley Interdisciplinary Reviews-nanomedicine and Nanobiotechnology (2016)
- Hydroxyapatite nanoparticles: preparation, characterization, and evaluation of their potential use in bone targeting: an animal study. Nuclear Medicine Communications (2016)
- Morphologic and Functional Study of Heterotopic Splenic Tissue Allografts in Rabbits. Experimental and Clinical Transplantation (2015)
- Morphologic and functional study of heterotopic splenic tissue allografts in rabbits. Experimental and Clinical Transplantation (2015)
- Study of the Zircon Processing Aiming the Recovery of Zirconium and Silica. Proceedings of the International Mining Congress and Exhibition of Turkey, IMCET (2015)
- Aptamers directly radiolabeled with technetium-99m as a potential agent capable of identifying carcinoembryonic antigen (CEA) in tumor cells T84. Bioorganic & Medicinal Chemistry Letters (2014)
- Tc-99m-labeled bombesin analog for breast cancer identification. Journal of Radioanalytical and Nuclear Chemistry (2013)
- 99mTc-labeled bombesin analog for breast cancer identification. Journal of Radioanalytical and Nuclear Chemistry (2013)
- Boron nitride nanotubes radiolabeled with 99mTc: Preparation, physicochemical characterization, biodistribution study, and scintigraphic imaging in Swiss mice. International Journal of Pharmaceutics (2012)
- Kit formulation for 99mTc-labeling of HYNIC-ΒAla-Bombesin (7-14). Applied Radiation and Isotopes (2012)
- Bombesin derivative radiolabeled with technetium-99m as agent for tumor identification. Bioorganic & Medicinal Chemistry Letters (2010)
Employment
- Assistant Professor, Michigan State University (2022-08-15)